Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 24 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Right Dose System Clear all

Conditions: Nicotine Addiction
Interventions: transcranial direct current stimulation (tDCS); Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 60 Years
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Increased Oxygen Demand
Interventions: Right Dose System; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Alzheimer Disease, Early Onset
Interventions: Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents, Positron Emission Tomography (PET), Amyvid, MK-6240, Dotarem, Blood draw, UR5e, Urine test; Device · Drug · Other + 2 more
Lead sponsor: Columbia University; Other
Eligibility: 50 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure
Interventions: HeartNet Ventricular Support System, Optimal Medical/Device Therapy; Device · Drug
Lead sponsor: Paracor Medical, Inc; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 29
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 26 more

Conditions: Duchenne Muscular Dystrophy
Interventions: Aim 2 Exercise group, Aim 1 Exercise Dosing, Aim 2 Control group; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 7 Years to 10 Years · Male only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Schizophrenia
Interventions: RBP-7000, Placebo, Risperidone; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 32
States / cities: Little Rock, Arkansas • Springdale, Arkansas • Cerritos, California + 25 more

Conditions: HIV Infections
Interventions: HIV-MAG vaccine, IL-12 pDNA adjuvant, VSV HIV gag vaccine, Placebo, Ichor Medical Systems TriGrid™ Delivery System (TDS) electroporation (EP) device; Biological · Device
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 5
States / cities: New York, New York • Rochester, New York • Philadelphia, Pennsylvania + 1 more

Conditions: Metabolic Diseases
Interventions: human hepatocyte transplantation, Preparative Radiation Therapy; Drug · Radiation
Lead sponsor: Ira Fox; Other
Eligibility: Up to 21 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism, Right Ventricular Dysfunction
Interventions: Alteplase, EKOS; Drug · Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 89 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Bay Shore, New York • Queens, New York

Conditions: Phobias, Claustrophobia, Social Phobia
Interventions: Extinction Training, Low-Level Laser Therapy, Sham Low-Level Laser Therapy; Behavioral · Device
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Pulmonary Embolism, Pulmonary Embolism Subacute Massive
Interventions: inhaled nitric oxide (iNO); Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hantavirus Pulmonary Infection, Immunisation
Interventions: Andes virus DNA vaccine, Placebo; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 49 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Asthma, Allergies
Interventions: Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage, Phlebotomy; Biological · Procedure
Lead sponsor: Andrew D. Luster, M.D.,Ph.D.; Other
Eligibility: 18 Years to 50 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pain, Postoperative, Opioid Use
Interventions: Liposomal bupivacaine, TAP block, Deposition of saline; Drug · Procedure
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Parkinson's Disease
Interventions: Real TMS, Sham TMS; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Patent Foramen Ovale
Interventions: Cardiox FDS; Device
Lead sponsor: Cardiox Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 7
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 4 more

Conditions: Asthma, Allergies
Interventions: Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage, PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging); Biological · Procedure
Lead sponsor: Andrew D. Luster, M.D.,Ph.D.; Other
Eligibility: 18 Years to 50 Years
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tibial Plateau Fracture, Pain, Postoperative
Interventions: Duloxetine, Placebo, Standard of care (SOC) for tibial plateau surgery; Drug · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Boston, Massachusetts • Valhalla, New York

Conditions: Stroke
Interventions: IV rt-PA alone, endovascular therapy; Drug · Other
Lead sponsor: Joseph Broderick; Other
Eligibility: 18 Years to 82 Years
Enrollment: 656 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 49
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 39 more

Conditions: Asthma
Interventions: Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage; Biological
Lead sponsor: Benjamin Medoff; Other
Eligibility: 18 Years to 50 Years
Enrollment: 313 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer, HER2-positive Breast Cancer
Interventions: HER2 Vaccine; Drug
Lead sponsor: Pravin T.P Kaumaya; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pulmonary Embolism, Right Ventricular Dysfunction, Right Ventricular Failure
Interventions: Ultrasound-facilitated, catheter-directed lower-dose fibrinolysis, Tissue Plasminogen Activator; Device · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma
Interventions: PEP-CMV, Temozolomide, Tetanus Diphtheria Vaccine; Biological · Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 3 Years to 39 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 13
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • Miami, Florida + 10 more

Conditions: Abdominal Trauma
Interventions: Focused Assessment with Sonography for Trauma (FAST), Bubble-Enhanced FAST (BEFAST); Diagnostic Test · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

tDCS Effects on Resisting Smoking: Dose Ranging Study

Demonstrating the Feasibility of a Novel Oxygen Delivery Device

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial

Strength Training in Duchenne Muscular Dystrophy

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

Hepatocyte Transplantation for Liver Based Metabolic Disorders

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training

Effect of iNO in Patients With Submassive and Massive PE

Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma

Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial

Cognitive Dysfunction in Parkinson's Disease

Cardiox Shunt Detection Technology Study

T Cell Effector and Regulatory Mechanisms in Asthma

Duloxetine Tibial Plateau

Interventional Management of Stroke (IMS) III Trial

Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

HER2 Vaccine for Locally Advanced Breast Cancer

Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury